Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. - Wikidata - wikimedia - TriplyDB

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

http://www.wikidata.org/entity/Q37259751

about

Fluorescent imaging of cancerous tissues for targeted surgery.Regulation of the latent-lytic switch in Epstein-Barr virus Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies Imaging and drug delivery using theranostic nanoparticles Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid Viral profiling identifies multiple subtypes of Kaposi's sarcoma.Bortezomib-induced Epstein-Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategies Proteasome inhibition in vivo promotes survival in a lethal murine model of severe acute respiratory syndrome.Gastric cancer: Classification, histology and application of molecular pathology.Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma.High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.Expression of EBV encoded viral RNA 1, 2 and anti-inflammatory cytokine (interleukin-10) in FFPE lymphoma specimens: a preliminary study for diagnostic implication in Pakistan Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication.K-bZIP Mediated SUMO-2/3 Specific Modification on the KSHV Genome Negatively Regulates Lytic Gene Expression and Viral Reactivation.Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies Imaging virus-associated cancer.Trichloromethane fraction of Incarvillea compacta induces lytic cytotoxicity and apoptosis in Epstein-Barr virus-positive gastric cancer AGS cells.Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma Lymphoepithelioma-like gastric carcinoma located in the lesser curvature of the gastric body: A case report and review of the literature Imaging techniques for Kaposi's sarcoma.Signal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes.Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication.The evolution of imaging in cancer: current state and future challenges.Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.Potential of protein kinase inhibitors for treating herpesvirus-associated disease.KSHV targeted therapy: an update on inhibitors of viral lytic replication.Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma.Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle.Virus reactivation: a panoramic view in human infections Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors Integrative systems control approach for reactivating Kaposi's sarcoma-associated herpesvirus (KSHV) with combinatory drugs.Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function.Tousled-like kinases modulate reactivation of gammaherpesviruses from latency.A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.Dosimetric effectiveness of targeted radionuclide therapy based on a pharmacokinetic landscape.

P2860

Q26830905-8BF6190B-F525-4424-A4BD-B001015B95BF Q27021366-45B7DADE-A225-4E09-966A-17D51B6D3751 Q27024034-18365547-798A-41F0-9B72-8E4E75B09B04 Q28551855-B9C5D25F-A7F8-4AA5-85DA-CC5346A9AE90 Q30449480-A790B61A-C471-486D-B11E-2260942CDDD5 Q34187225-F3168EDE-6DC6-44A5-95F0-A50242D33348 Q34237734-F6722485-55DC-4B38-AA66-CF5073B5921C Q34245230-A9190BD2-B9E6-4F18-89CC-AF92076C8AE9 Q34291012-2E3D736E-4271-4F78-B709-8DA7C0B225B3 Q34642023-8B41CED5-5343-4AD7-A55C-AB421E5A3712 Q35067397-B76BD1FA-C016-4063-BFD4-A710F01B436B Q35127955-D8953397-CF65-46D0-8934-890EFD6A37C1 Q35168623-91BEE5DB-3A35-4D06-A731-6F9872DA751A Q35660314-3D3359B4-EBAA-4139-8499-C8B46A36108F Q35703276-88F6FD4B-05F5-4B37-A159-43AF6F4BB3B5 Q35733719-C9E243A6-0388-4E2F-A00E-80DE6B7A22CC Q35779961-59621CE4-93DD-44CF-882D-7ED2A1C9F524 Q35829978-6B3FA348-6D88-4C09-8C25-298522AA3849 Q36015054-F8428E38-B031-4473-9C57-D4E6FA9FEA23 Q36123092-F1710BDF-CAD3-4FA4-8A41-A59CB2B1118F Q36346985-29216E99-BE81-4BEA-B82E-720850B8F9F5 Q36544568-6A4B5613-4B44-40FF-8063-D0681643BDD4 Q36640171-0271B39D-8CFF-4021-8F84-67B242BDFDEF Q37010086-D831BCD6-FA8E-4190-AA61-5DC217B983B9 Q37252690-B749C68E-CB53-4FD0-A28F-89212D884AD3 Q37525707-090E0DEF-F2C1-42C4-8180-ECAC29C54D4C Q37848518-EB260315-707F-4FEB-8378-C0F5CD115B4E Q38052131-13BA689B-820C-4C5F-810A-ECDEA8557C3C Q38100859-4588DEC2-4A18-419B-8799-2F174B209012 Q38271135-411EDCDA-E566-4924-832A-885FB53CDC02 Q39324686-EB9C3521-06FC-4571-8D65-BA1139F8EB58 Q39575256-D81B294F-3955-4DAA-86AF-092FF57213F3 Q39723484-FCC16A52-0438-4D54-A713-361528E4FCA6 Q39778922-718FAF05-53C3-4E6E-96BD-A067086A016C Q39784255-4B5900F8-CB04-4476-9164-1535AEAB10FC Q41674995-96AC4F41-907B-455B-9295-C3E6B474969D Q41983297-058F4F44-CA8E-4FC2-A7B4-E7ED49D96F0A Q42274743-64EA5A14-1D5F-4C0B-9F11-35119BAC9A88 Q42763210-8EA58569-3D19-4C3D-8C85-3E3BABAC6A37 Q42961805-E79ED0B7-9FFF-41B5-86C3-6072C4EFA405

P2860

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

http://www.wikidata.org/entity/Q37259751

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

@en

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

@nl

type

label

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

@en

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

@nl

prefLabel

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

@en

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

@nl

P1433

Q37259751-1D6052A2-4F1A-458B-853B-056D5AFB9B9A

P1476

Q37259751-5E108A79-E588-464B-A4F8-DA96A241AAF8

P2093

Q37259751-03E25606-6A04-496D-923D-A78971F633BC

Q37259751-124EB124-4E2D-40C8-97B5-353C586FAE34

Q37259751-16A591ED-85F9-4D61-B5D5-81A796030F2B

Q37259751-2089DF5E-A9EB-459C-ADB9-36D92FDD017C

Q37259751-43CBEF48-6FB8-404D-8755-BA424B3EA70B

Q37259751-74FD3AFE-A047-48FD-B608-940824E8D097

Q37259751-D348AA2B-AD7E-4BDF-8440-CF1209CB6ADC

Q37259751-DD16A1CD-41F0-4048-B2CF-2F277DE970D9

Q37259751-FD34DFD3-BE63-42AE-9CC4-1F5131123909

P2860

Q37259751-07EE2107-E329-48EC-B726-3C5B0A1D5FDC

Q37259751-35361C0A-6201-4641-9FBD-4B453EF43656

Q37259751-37AF013D-E6C8-404F-9980-8721C92C664A

Q37259751-396D17B2-4829-424A-9FBF-33D85098E977

Q37259751-47068CCE-CF90-443A-BC51-81ABC05E8C06

Q37259751-481FCC79-2769-43FA-B467-E754FD97C7EF

Q37259751-549B77A4-5233-416C-97D0-A8B7F321217D

Q37259751-55B80CDD-849F-46F2-8DA3-7FC59DAB358C

Q37259751-56BED06B-EB02-46E1-8D28-64B6FF99EB21

Q37259751-571F29BB-3E2D-42F4-A600-36921A590855

P2888

Q37259751-0EE82788-6A6B-4231-A62A-4F96DBBE5891

P304

Q37259751-45ADFE87-D78D-4F1E-A2A2-445331931A8A

P31

Q37259751-6DABDE47-30C9-4C5A-BCC1-9C74EE2A43A8

P356

Q37259751-330075FB-709E-42A8-B0F0-F07EA7A15499

P407

Q37259751-1416C0BF-3A6C-4A29-AA94-30B3B47FDF9B

P433

Q37259751-34C34291-C85E-4330-AEA2-AD6055390DBE

P478

Q37259751-BC033571-5094-4857-8331-366B9CAD888D

P50

Q37259751-0C6F05FF-5FA3-4ADF-9171-321F1FC0225A

Q37259751-66C6AC05-4D21-48C5-B56A-66AE20062925

Q37259751-9EFE60CE-484A-49B6-B729-BCCE1BCFBB8B

P577

Q37259751-69A230AF-F371-4BF2-915A-099EA2496F70

P5875

Q37259751-AAB2B641-4AB3-4B63-8BBE-8A5FEB1A76A4

P698

Q37259751-9EC799AD-76B4-4231-B9A0-87C91107AC57

P921

Q37259751-E19741E2-F96A-457C-A542-CD132259933B

P932

Q37259751-2E5C8C3A-DBFB-45BF-8F8D-C0D9DC1E9CDB

P356

P1433

Nature Medicine

P1476

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

@en

P2093

Catherine A Foss

http://www.w3.org/2001/XMLSchema#string

De-Xue Fu

http://www.w3.org/2001/XMLSchema#string

Ja-Mun Chong

http://www.w3.org/2001/XMLSchema#string

James J Fox

http://www.w3.org/2001/XMLSchema#string

Jianmeng Chen

http://www.w3.org/2001/XMLSchema#string

Martin G Pomper

http://www.w3.org/2001/XMLSchema#string

Masashi Fukayama

http://www.w3.org/2001/XMLSchema#string

Richard F Ambinder

http://www.w3.org/2001/XMLSchema#string

Yvette Tanhehco

http://www.w3.org/2001/XMLSchema#string

P2860

Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells.

Global cancer statistics, 2002

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT

Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy.

Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents

Epstein-Barr virus and gastric carcinoma

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase.

Therapeutic potential of 90Y- and 131I-labeled anti-CD20 monoclonal antibody in treating non-Hodgkin's lymphoma with pulmonary involvement: a Monte Carlo-based dosimetric analysis.

P2888

P304

1118-1122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.1864

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Jeanne Kowalski

P577

2008-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23242826

http://www.w3.org/2001/XMLSchema#string

P698

18776891

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2709824

http://www.w3.org/2001/XMLSchema#string